Patent details

Basic Information

Publication number:

91778

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP060751757

Legal Status:

Expired

Application number:

91778

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/10/614/001

Marketing Authorization Type:

Marketing Authorization Date:

17/03/2010

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

13/01/2011

First Marketing Authorization date:

17/03/2010

Grant date:

14/03/2011

Activation date:

20/06/2022

Publication date:

14/03/2011

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

17/03/2025

SPC Extension Expiration:

17/03/2025

Rejection date:

Withdrawal date:

Owner

From:

08/05/2017

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:

13/01/2011

To:

08/05/2017

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

1

Name:

KIRKPATRICK

From:

08/01/2018

Address:

Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)

To:

2

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

13/01/2011

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

07/01/2019

Inventor

Name:

Costantino Paolo

Address:

Italy (IT)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

3

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000137A

Date Registered:

08/05/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

21/05/2024

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
07/01/2019	Publication	1
08/05/2017	Request For Change	11
20/03/2018	Incoming Correspondence (Post)	3
08/01/2018	Power Of Attorney	2
07/01/2019	Outgoing Correspondence	1
24/01/2018	Outgoing Correspondence	1
09/05/2017	Outgoing Correspondence	1